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1086Objectives: A novel Y-shaped baffle has been proposed for the Fontan operation with promising initial results.
However, previous studies have relied either on idealized models or a single patient-specific model. The objec-
tive of this study is to comprehensively compare the hemodynamic performance and hepatic blood flow distri-
bution of the Y-graft Fontan baffle with 2 current designs using multiple patient-specific models.
Methods: Y-shaped and tube-shaped grafts were virtually implanted into 5 patient-specific Glenn models form-
ing 3 types of Fontan geometries: Y-graft, T-junction, and offset. Unsteady flow simulations were performed at
rest and at varying exercise conditions. The hepatic flow distribution between the right and left lungs was care-
fully quantified using a particle tracking method. Other physiologically relevant parameters such as energy dis-
sipation, superior vena cava pressure, and wall shear stress were evaluated.
Results: The Fontan geometry significantly influences the hepatic flow distribution. The Y-graft design im-
proves the hepatic flow distribution effectively in 4 of 5 patients, whereas the T-junction and offset designs
may skew as much as 97% of hepatic flow to 1 lung in 2 cases. Sensitivity studies show that changes in pulmo-
nary flow split can affect the hepatic flow distribution dramatically but that some Y-graft and T-junction designs
are relatively less sensitive than offset designs. The Y-graft design offers moderate improvements over the tra-
ditional designs in power loss and superior vena cava pressure in all patients.
Conclusions: The Y-graft Fontan design achieves overall superior hemodynamic performance compared with
traditional designs. However, the results emphasize that no one-size-fits-all solution is available that will univer-
sally benefit all patients and that designs should be customized for individual patients before clinical application.
(J Thorac Cardiovasc Surg 2012;143:1086-97)The impact of geometry on Fontan hemodynamics is now
widely accepted in the engineering and clinical communi-
ties.1–4 Recent advances in computational fluid dynamics,
computer-aided design, magnetic resonance imaging
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specific models, steady to unsteady flow, and trial and error
to optimal design.5–9e Department of Mechanical and Aerospace Engineering,a University of Cal-
a San Diego, La Jolla, Calif; INRIA Paris-Rocquencourt,b Le Chesnay Ce-
France; and Institute for Computational and Mathematical Engineering,c
rtment of Cardiothoracic Surgery,d and Departments of Pediatrics and Bioen-
ring,e Stanford University, Stanford, Calif.
rk was supported by the American Heart Association, a Burroughs Wellcome
Career Award at the Scientific Interface, a Leducq Foundation Network of
lence grant, and INRIA associated team grant.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Dec 1, 2010; revisions received May 13, 2011; accepted for
ation June 27, 2011; available ahead of print Sept 12, 2011.
for reprints: Alison L. Marsden, MD, Department of Mechanical and Aero-
Engineering, University of California San Diego, 9500 Gilman Dr, La Jolla,
2093-0411 (E-mail: amarsden@ucsd.edu).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2011.06.042
The Journal of Thoracic and Cardiovascular SurIn the earlist extracardiac Fontan procedures, the inferior
vena cava (IVC) was anastomosed to the pulmonary arteries
(PAs) via a straight polytetrafluoroethylene graft (Gore-Tex
graft; W. L. Gore & Associates, Inc, Flagstaff, Ariz) form-
ing a T-junction. An offset design derived from simulations5
was then adopted by surgeons to reduce energy losses and
remains standard of care in most extracardiac procedures.
Recently, 2 research groups 7,10 proposed a new Y-shaped
connection to replace current designs. First, Soerensen and
coworkers10 bifurcated both the superior vena cava (SVC)
and IVC. Simulations using an idealized model with steady
inflow conditions demonstrated lower energy loss. Given
the technical difficulties and need for increased synthetic
material, this modification was not pursued in clinical prac-
tice. Marsden and coworkers7 introduced an IVC-only bi-
furcated Fontan modification. A detailed comparison of
energy efficiency, Fontan pressures, and hepatic flow distri-
bution demonstrated superior Y-graft performance.7 An op-
timization process was then used to systematically explore
design parameters and hemodynamics for an idealized
Y-graft model.8 Although the preliminary studies showed
the Y-graft design to improve hemodynamics overall, it
has not yet been confirmed that the superiority of the Y-graft
is universal.gery c May 2012
Abbreviations and Acronyms
IVC ¼ inferior vena cava
LPA ¼ left pulmonary artery
MRI ¼ magnetic resonance imaging
PA ¼ pulmonary artery
RPA ¼ right pulmonary artery
SVC ¼ superior vena cava
WSS ¼ wall shear stress
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DComplications after the Fontan procedure, including
diminished exercise capacity, thromboembolic complica-
tions, protein-losing enteropathy, arteriovenous malforma-
tions, ventricular dysfunction, and arrhythmias, continue
to present serious clinical challenges despite postoperative
survivals upwards of 90%.11 Among these, the develop-
ment of pulmonary arteriovenous malformations is known
to be linked to hepatic flow distribution and is therefore
an obvious target for improvement via simulation-based de-
sign. Although the pathogenesis of pulmonary arteriove-
nous malformations is unknown, several studies have
revealed a clear link between the absence of hepatic venous
return and the development of pulmonary arteriovenous
malformations, and reversal of pulmonary arteriovenous
malformations has been achieved by correcting the uneven
hepatic flow distribution.12 Although the energy dissipation
of different Fontan geometries has been investigated in
numerous studies1-3,5,6 only a few studies4,7,13-16 have
quantified the hepatic flow distribution in in vitro or
simulation studies.
The purpose of this article is to evaluate the potential per-
formance of the Y-graft Fontan procedure in simulation as
a step toward clinical implementation. Multiple virtual pa-
tient models are used, and multiple parameters4 are evalu-
ated for each, with particular attention paid to the hepatic
flow distribution.METHODS
Geometric Model Construction
Virtual surgery was performed on 5 models by implanting a Y- or tube-
shaped graft into patient-specific Glenn models17 constructed from MRIs.
All patients gave consent as part of an institutional review board approved
protocol at Lucile Packard Children’s Hospital (Stanford University).
Model construction was performed using a custom version of the open
source Simvascular software package,18 as in our previous work.7
Geometric parameters were chosen on the basis of our previous optimi-
zation study.8 AY-graft with a 20-mm diameter trunk and 15-mm diameter
branches was chosen for all patients. The T-junction and offset models were
constructed with a 20-mm diameter tube-shaped graft following common
clinical practice, and resulting models are shown in Figure 1.
In the virtual implantation, the centerline paths of the SVC and PA
anatomy of the original Glenn models were left unchanged. The space
created by the deflation of the right atrium during the Fontan procedureThe Journal of Thoracic and Carwas accounted for in IVC placement during virtual surgery. In addition,
the PA segmentations were enlarged to match the baffle size to avoid cre-
ating unrealistic stenoses. Although this is purely a simulation study, all
models were constructed under guidance of a surgeon to replicate as
closely as possible a realistic surgical implementation of the intended
design.
Patient B has a left PA (LPA) stenosis, which is commonly observed
in Fontan patients owing to aortic arch override. Three potential Y-graft
designs were proposed for this patient model. In Y-graft I, the stenosis is
relieved by placing the anastomosis of the left branch at the stenosis. In
Y-graft II, the left branch is anastomosed distal to the stenosis, without
relieving it. In Y-graft III, the left branch is also anastomosed distal to
the stenosis, but the stenosis is relieved. Patient E has heterotaxy and
a right PA (RPA) stenosis. Instead of an LPA offset connection, the baffle
is anastomosed to the RPA in a mirror image of the other patients, de-
noted as offset I. The stenosis is relieved in the Y-graft I, T-junction,
and offset I designs. An LPA–offset connection without relieving the ste-
nosis (II) is also constructed. We redesigned the Y-graft for patient E, de-
noted as Y-graft II, by bringing the left branch closer to the SVC–PA
junction and less anteriorly convex, based on the simulation results of
Y-graft I.
Flow Simulation and Boundary Conditions
Flow simulations were performed with a stabilized finite element
Navier-Stokes solver,19 assuming rigid walls and Newtonian flow with
a density of 1.06 g/cm3 and viscosity of 0.04 g/(cm s). MeshSim (Simme-
trix, Inc, Clifton Park, NY) was used to generate tetrahedral meshes auto-
matically and anisotropic mesh adaptation was performed to ensure mesh
convergence. Final meshes consisted of approximately 1 to 1.5 million
elements.
DuringMRI, phase-contrast MRI slices were acquired in the SVC, IVC,
LPA, and RPA for each Glenn patient. The SVC waveform from phase-
contrast MRI was applied directly to the SVC inflow face by mapping it
to a parabolic profile. Because the IVC flow waveforms were acquired in
the Glenn patients before surgery, when the IVC was still connected to
the right atrium, these waveforms exhibited higher cardiac pulsatility and
less respiratory pulsatility compared with typical Fontan patients.20 To ac-
count for this, the amplitude of the IVC waveform of each Glenn patient
was scaled to match typical Fontan data using 4 patients from a previous
study, while keeping the mean the same. Additionally, a respiratory model
was superimposed on the scaled IVC waveform as done in our previous
work.6
A 3-element Windkessel circuit model (resistor–capacitor–
resistor)21–23 was applied at each outlet. Predicting changes in
pulmonary resistance after Fontan surgery remains an open question.
However, inasmuch as this study aims to model immediate postoperative
flow conditions, we have assumed that the downstream resistances do
not change significantly in the short period after the surgery. Therefore,
the same parameters for the Windkessel model were used for the Glenn
and Fontan simulations in all patients, so that the comparison of
postoperative states among patients remains consistent.
Exercise flow conditions were simulated by increasing IVC flow and de-
creasing outflow resistances, as done in our previous work.6 The mean IVC
flow ratewas increased by 2 and 3 times (23, 33) to simulate exercise con-
ditions, and the total resistances of each branch was decreased by 5% and
10%, respectively.
Determination of Performance Parameters
Mean SVC pressure, wall shear stress (WSS), and power loss were com-
puted with standard methods.7 Lagrangian particle tracking15 was per-
formed to quantify the hepatic flow distribution in different surgical
designs (Figure 2).
It is widely known that the ratio of IVC/SVC flow and LPA/RPA resis-
tances vary widely among patients. Although ideally one would like todiovascular Surgery c Volume 143, Number 5 1087
FIGURE 1. Original Glenn models and variations of Fontan geometries for 5 patients. The Y-graft includes a 20-mm trunk and two 15-mm branches. The
size of the tube-shaped graft is 20 mm. Patients B and E have a stenosis in the left and right pulmonary arteries, respectively, denoted by arrows.
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every case. Conservation of mass analysis (see Appendix 1) allows us to
determine the theoretical optimum for hepatic flow distribution in a given
situation.
Table 1 lists the theoretical best hepatic flow distribution for the 5 pa-
tients in our study. We observe that a perfect 50:50 split can theoretically
exist for 4 of the 5 patients, with patient A as the exception, for whom
the RPA receives more than 80% of the total inflow.
The main focus of this study is the evaluation of Fontan designs in
the immediate postoperative period. However, it is unlikely that pulmo-
nary resistances remain constant over time for most Fontan patients
owing to age, growth, and remodeling. We therefore assess the robust-
ness of the hepatic flow distribution to changes in the pulmonary flow
split for different surgical designs. For each patient, the Y-graft, offset,
and T-junction designs were analyzed under rest conditions for a range
of pulmonary resistances to compare the robustness of different
designs.1088 The Journal of Thoracic and Cardiovascular SurRESULTS
Hepatic Flow Distribution
The percentages of hepatic flow to the RPA and LPA, and
differences from the theoretical optima at rest, 23, and 33
exercise conditions, are shown in Figure 3. In patient A, the
Y-graft design is closest to the theoretical optimum, even
though patient A’s right lung receives more than 80% of
the total venous return. So that we can illustrate how the ge-
ometry influences the hemodynamics of hepatic flow distri-
bution, the velocity fields for 3 patients are shown in
Figure 4. In the T-junction design of patient A, the SVC
jet clearly blocks the hepatic flow entering the LPA and
skews it to the RPA. In contrast, the Y-graft design effec-
tively mitigates this effect.gery c May 2012
FIGURE 2. Visualization of the particle tracking in the model Y-graft II for patient B. Particle tracking is terminated when particles are washed from the
model. LPA, Left pulmonary artery; RPA, right pulmonary artery.
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ing the stenosis with a proximal anastomosis allows the
SVC jet to enter the baffle and hinder hepatic flow. How-
ever, Y-graft II, which leaves the stenosis intact, achieves
a nearly perfect 50:50 distribution at rest. Overall, for pa-
tient B, Y-graft II has the best hepatic distribution at rest,
whereas the offset design performs best at exercise.
In patient C, the T-junction and offset designs skew he-
patic flow to the RPA and LPA, respectively. In both patients
C and D, when the pulmonary flow split is close to 50:50,
the offset design has poor performance with a highly
skewed hepatic flow split. Overall, for patient C, the Y-graft
design has the best hepatic performance, although none of
the designs achieves the theoretical optimum.
In patient D, although the SVC anastomosis is inclined to
channel flow to the LPA, Figure 4 shows that the lower sec-
tion bc of the SVC is ineffective in changing the direction of
flow. Improvements are observed in both the Y-graft and
T-junction during exercise, and the Y-graft achieves a nearlyTABLE 1. MRI inflow rates, MRI outflow splits, and the TOHFS at
rest for the 5 study patients
Patient
Age
(y)
BSA
(m2)
IVC
(mL/s)
SVC
(mL/s)
RPA/LPA
flow split
TOHFS
(RPA/LPA)
A 4.8 0.63 13.4 14.4 81/19 61/39
B 3.9 0.66 12.6 15.3 63/37 50/50
C 2.8 0.56 6.3 15.2 54/46 50/50
D 3.0 0.61 14.8 27.8 55/45 50/50
E 3.0 0.74 12.7 19.4 70/30 50/50
MRI, Magnetic resonance imaging; TOHFS, theoretical optimal hepatic flow splits;
BSA, body surface area; IVC, inferior vena cava; SVC, superior vena cava; RPA, right
pulmonary artery; LPA, left pulmonary artery.
The Journal of Thoracic and Car50:50 split in the 33 exercise case. Overall, for patient D,
the T-junction does best at rest, whereas the Y-graft does
best at exercise.
In patient E, the T-junction, offset I, and Y-graft I de-
signs skew hepatic flow strongly to the RPA with a 70:30
(RPA/LPA) pulmonary flow split because of the smooth
graft and the low distal RPA resistance. For the T-junc-
tion design, hepatic flow distribution remains constant
with exercise, whereas Y-graft I progressively improves
the distribution from rest to exercise. The skewed hepatic
flow is corrected in the Y-graft because the SVC jet sup-
presses hepatic flow entering the RPA from the right
branch (Figure 4). Overall, for patient E, the offset II de-
sign results in the best hepatic flow distribution at rest
and exercise.Robustness Test
The hepatic flow distribution in the Y-graft, offset and
T-junction designs for 3 different pulmonary flow splits,
and their averaged deviations for a 25% change in flow
split, are shown in Figure 5. The optimal design depends
heavily on the pulmonary flow split for individual patients.
The Y-graft and T-junction designs are relatively more
robust in 2 and 3 patients, respectively. Although the
T-junction design underperforms for most patients with
the original flow split, deviations in hepatic flow distribu-
tion are smaller than those of the offset design.SVC Pressure
Pressure levels increase in all models under exercise con-
ditions. The SVC pressure levels in the Y-graft are the samediovascular Surgery c Volume 143, Number 5 1089
FIGURE 3. Left, Hepatic flow distribution at rest. Right, Differences (percentage of the IVC flow) from the theoretical optima for each design at rest and
exercise. Note that the theoretical optima for patient A at rest, 23, and 33, are 61/39, 70/30 and 72/28, respectively, and that a 50:50 split cannot be achieved
in theory. IVC, Inferior vena cava; RPA, right pulmonary artery; LPA, left pulmonary artery.
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FIGURE 4. Time-averaged velocity vectors in the Y-graft and T-junctionmodels for patients A, D, and E. In the T-junction design for patient A, the SVC jet
blocks the hepatic flow entering the LPA. In patient D, most SVC flow is directed to the RPA owing to a curved SVC. In patient E, Y-graft II improves the
hepatic flow distribution by having a straight proximal branch for the RPA, in which the SVC jet blocks hepatic flow going to the RPA from the right branch,
compared with Y-graft I. SVC, Superior vena cava; LPA, left pulmonary artery; RPA, right pulmonary artery.
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signs at rest and exercise conditions in 5 patients (Table 2).
This finding agrees with our previous work, which
identified a pressure shielding effect causing lower SVC
pressure with the Y-graft design owing to the lack of
a head-on flow collision in the junction.7Power Loss
Table 2 gives the power loss values for the Y-graft,
T-junction, and offset designs for each patient. Energy
loss increases with increasing exercise levels. The T-junc-
tion designs result in the highest energy losses in mostThe Journal of Thoracic and Carpatients owing to a direct flow collision, agreeing with pre-
vious studies.WSS
Mean WSS values on the IVC graft generally increase
with increasing inflow rates (Table 2). Exceptions to this
are the T-junction and offset designs for patient C, in
whom the SVC jet enters the tube-shaped graft and in-
creases theWSS at a low IVC flow rate. The Y-graft and off-
set designs result in lower mean WSS values on the graft
than the T-junction design. This is consistent with the fact
that the T-junction design usually causes more energydiovascular Surgery c Volume 143, Number 5 1091
FIGURE 5. Hepatic flow distribution changes with variations in pulmonary flow split. Patients’ original pulmonary flow splits are marked by the arrows at
the x-axis. The table shows the averaged deviations with respect to the original hepatic flow distribution for a 25% change in pulmonary flow split. IVC,
Inferior vena cava; RPA, right pulmonary artery.
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patients is shown in Figure 6. The other 3 patients exhibited
similar behavior.
Averaged Results
By averaging the hepatic distributions and power losses
in the best performing Y-graft, T-junction, and offsetTABLE 2. Mean SVC pressure (mm Hg), power loss (mW), and mean (in
models. Compared with the best Y-graft design for the same patient, incre
Patient Model
SVC pressure
Rest 23 33
A Y-graft 15.3 19.4 22.9
T-junction 15.5 19.6 23.4
Offset 15.4 19.7 23.4
B Y-graft I 12.9 16.7 19.9
Y-graft II 12.8 16.6 19.8
Y-graft III 12.8 16.6 19.8
T-junction 13.1 17.1 20.5
Offset 13.0 17.0 20.4
C Y-graft 10.4 11.9 13.0
T-junction 10.4 11.9 13.0
Offset 10.4 11.9 13.1
D Y-graft 10.8 13.5 15.8
T-junction 10.9 13.7 16.1
Offset 10.8 13.6 16.0
E Y-graft I 22.9 27.7 31.7
Y-graft II 22.8 27.6 31.7
T-junction 22.9 27.8 31.8
Offset I 22.8 27.6 31.6 
Offset II 23.4 28.6 33.1
SVC, Superior vena cava; WSS, wall shear stress; IVC, inferior vena cava.
1092 The Journal of Thoracic and Cardiovascular Surdesigns over the 5 patients in the study (see Figure 7), we
found that the Y-graft design has the lowest average differ-
ence from the theoretical optima under rest and exercise
conditions (ie, the Y-graft design results in more even he-
patic flow distribution than other designs overall) and that
the distribution approaches the theoretical optima with in-
creasing exercise level. Significant differences (P< .05)space) WSS magnitude (dynes/cm2) on the IVC graft for the Fontan
ases in power loss for the T-junction and offset designs are also shown
Power loss Mean WSS
Rest 23 33 Rest 23 33
5.1 14.5 24.9 2.3 4.6 7.2
16% 14% 14% 4.5 5.9 7.9
10% 15% 17% 1.9 4.5 7.4
2.4 5.4 8.6 6.5 6.5 8.7
2.0 4.6 7.5 2.2 5.2 7.6
2.0 4.7 7.6 2.3 4.6 7.0
60% 70% 76% 6.1 6.8 9.0
40% 57% 64% 3.1 5.1 7.4
1.8 2.9 4.1 3.0 3.3 4.2
0% 7% 5% 5.5 5.4 5.3
0% 10% 15% 3.0 2.2 2.4
5.8 12.8 19.9 3.8 6.9 9.6
10% 15% 17% 4.0 4.5 5.9
5% 11% 16% 2.5 6.0 9.8
5.14 10.8 17.1 3.9 5.7 8.0
4.7 9.7 15.6 2.9 4.7 7.15
14% 15% 15% 5.4 7.1 10.2
1% 2% 5% 3.1 6.6 6.8
65% 86% 90% 2.7 4.6 8.1
gery c May 2012
FIGURE 6. Contours of time-averaged wall shear stress (dynes/cm2) at rest for patients A and C.
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loss between the Y-graft and T-junction designs.
DISCUSSION
In this study, a multiparameter approach was used to
evaluate 3 Fontan designs in 5 patients, with particular fo-
cus on hepatic flow distribution. This multiple-patient se-
ries has demonstrated that the Y-graft design can
significantly improve hepatic flow distribution and moder-
ately improve energy loss and SVC pressure. However, our
results emphasize that no one-size-fits-all design achieves
satisfactory hepatic distributions in all patients. The hemo-
dynamics affecting flow distribution are nonintuitive inFIGURE 7. Averaged differences from the theoretical optima and power losse
patients B and E are used. The differences between the Y-graft and T-junction
The Journal of Thoracic and Carmany cases, and small differences in geometry can dramat-
ically influence results. Because these subtle changes are
not easily elucidated with standard imaging modalities,
simulations should be used to determine the best candi-
dates for a Y-graft preoperatively and to refine the graft de-
sign for each patient.
Hepatic Flow Distribution
Hepatic flow distribution in the Fontan is driven by mul-
tiple factors. The SVC jet can prevent hepatic flow from
reaching the LPA, and this was the leading cause of
uneven hepatic flow distribution in our study, agreeing
with previous results of Dasi and associates.16 Althoughs over 5 patients. The best performing of the Y-graft and offset designs for
designs are statistically significant (*P<.05).
diovascular Surgery c Volume 143, Number 5 1093
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T-junction design effectively mixes the IVC and SVC
flows and distributes the hepatic flow evenly,13 these phe-
nomena were not observed uniformly in the patient-
specific geometries in our study. The Y-graft design dis-
tributes hepatic flow more evenly than the T-junction in
most patients, but the wrong choice of Y-graft may lead
to unfavorable hemodynamics. The LPA–offset design
generally achieves satisfactory hepatic distribution in pa-
tients with high LPA resistance but an unfavorable distri-
bution in patients with an equal pulmonary flow split.
This result is consistent with previous work of Bove and
colleagues,14 which shows that the IVC flow in the total
cavopulmonary connection and traditional extracardiac
Fontan models is skewed to the LPA with a total pulmo-
nary flow split close to 50:50.
The nonintuitive result for patient D demonstrates that
the geometry of the SVC and relevant boundary conditions
plays an important role in distributing the IVC and SVC
flows. The hepatic flow distribution depends on the SVC
flow distribution (equation 2) with an inverse relationship
between the percentages of hepatic and SVC flow going
to the RPA. Thus the effect of the SVC–PA anastomosis
on the hepatic flow distribution should be carefully consid-
ered in surgical planning for the Glenn procedure.
Although the maximum change in hepatic flow distribu-
tion from rest to exercise was less than 20%, values gener-
ally approached their theoretical optima during exercise.
When the IVC flow rate is increased during exercise, the in-
teraction between the 2 caval flows in the T-junction design
generally enhances mixing and distributes hepatic flow
more evenly. Salim and associates24 showed that the contri-
bution of IVC flow to the cardiac output increases from
45% at 2.5 to 3 years old to 65% (the adult value) at 6.6
years old. In our study, 45% to 48% of systemic venous re-
turn is contributed by the IVC in 2 patients (mean 4.3 years),
whereas the IVC contribution is between 29% and 35% in
3 patients (mean 2.9 years). Thus, simulations under exer-
cise conditions may reveal some trends in the hepatic flow
distribution with increasing age, although changes in distri-
bution of caval flow to the PAs with age are still unknown.25
Our robustness test confirms that hepatic flow distribu-
tion depends strongly on the pulmonary flow split. For
some patients, the Y-graft design is relatively more robust
than the offset design for a wide range of flow conditions
with less chance to skew all IVC flow to one lung, but
this characteristic is not universal for all Y-graft designs. Al-
though the T-junction design skews hepatic flow with the
patients’ original pulmonary flow splits, it performs better
under the conditions with a high RPA resistance owing to
a slight RPA–offset for the anastomosis. Thus, the optimal
working condition for the LPA–offset design is opposite.
No design emerged as the clear winner over a wide range
of flow splits.1094 The Journal of Thoracic and Cardiovascular SurPower Loss
Compared with traditional designs, the Y-graft design re-
duces energy dissipation by bifurcating the IVC to decrease
flow competition. The Y-graft design reduces energy loss at
rest by 5% to 27% in 4 of 5 patients compared with the off-
set design. The differences in energy loss are more pro-
nounced during exercise, agreeing with previous work.SVC Pressure
It is clinically widely accepted that lower Fontan pressure
generally correlates with better outcomes. Overall, the
Y-graft design offers moderate reductions in the SVC pres-
sure compared with the T-junction and offset designs. In the
T-junction design, a higher SVC pressure is usually required
to overcome competing flow from the IVC. However, the
average SVC pressure differences are not as pronounced
as those reported in our previous work,7 likely because
IVC flow rates were lower in the younger patients in this
study. This trend suggests that the significance of the pres-
sure shielding effect observed with the Y-graft may increase
as patient’s age and their relative IVC flow increases.WSS
TheY-shaped grafts have lowermeanWSSvalues than the
tube-shaped grafts. These results are qualitatively consistent
with our previous work on idealized Y-graft shape optimiza-
tion,8 which shows a trade-off between energy efficiency and
areas of lowWSS.Whereas theWSSvalues in theY-graft are
generally comparable with values in offset designs, further
investigation into this issue is warranted, and in our current
clinical initial implementation of this surgical modification,
we have chosen to exclude patients with known thrombotic
tendency. The impingement of SVC flow results in a rela-
tively high WSS region in the intervening segment of the
PA (Figure 6), which does not suggest an increased likeli-
hood of flow stasis and thrombus formation in that region.Ranking
On the basis of power loss and hepatic flow distribution,
the proposed surgical designs are ranked for each patient
(Table 3) at rest and exercise. For energy loss, the Y-graft
design is superior to the others in 4 of 5 patients regardless
of rest or exercise conditions, and offset I is superior in pa-
tient E. However, more variations emerge in the ranking on
the basis of the hepatic flow distribution.
For patients A and C, the Y-graft design is clearly the final
winner, inasmuch as it was uniformly ranked first in both en-
ergy loss and hepatic flowdistribution. For patient B, the off-
set design provides 10% improvement in the hepatic flow
distribution at exercise, with better robustness to the pulmo-
nary flow split, but produces over 40%more power loss than
Y-graft II. We therefore select Y-graft II as the final candi-
date for patient B. For this patient, we note that Y-graft IIIgery c May 2012
TABLE 3. Ranking of energy loss and hepatic flow distribution for
each patient
Patient Model
Power loss Hepatic flow Recommended
designsRest 23 33 Rest 23 33
A Y-graft 1 1 1 1 1 1 U
T-junction 3 2 2 3 3 3
Offset 2 3 3 2 2 2
B Y-graft I 3 3 3 5 5 5
Y-graft II 1 1 1 1 2 2 U
Y-graft III 2 2 2 3 3 3
T-junction 5 5 5 4 4 4
Offset 4 4 4 2 1 1
C Y-graft 1 1 1 1 1 1 U
T-junction 3 2 2 2 2 3
Offset 2 3 3 3 2 2
D Y-graft 1 1 1 2 1 1 U
T-junction 3 3 3 1 1 2
Offset 2 2 2 3 3 3
E Y-graft I 3 3 3 3 3 3
Y-graft II 2 2 2 2 2 2 U
T-junction 4 4 4 4 4 5
Offset I 1 1 1 5 5 4
Offset II 5 5 5 1 1 1
The ranking of the hepatic flow distribution is based on the differences from the the-
oretical optima. In patients C and D, there are two designs tied for the hepatic flow
distribution.
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while keeping the power loss almost unchanged. If we
were to weight the robustness more heavily, then Y-graft
III would likely be the recommended choice. For patient
D, the Y-graft design is chosen because of lower energy
losses and progressive improvements in the hepatic flow dis-
tribution during exercise, but the T-junction would be pre-
ferred if the robustness were weighted more heavily than
the power loss. For patient E, Y-graft II is chosen because
it is well balanced between energy loss and the hepatic
flow distribution, and it is more robust to changes in the pul-
monary flow split comparedwith other designs. These surgi-
cal recommendations are limited to the patients we studied.
Generalization of these choices should be made carefully,
inasmuch as metrics used in this study could change as addi-
tional clinical data are obtained in future work. The reader
should be cautioned that not all variants of theY-graft design
that we tested in this study performedwell. However, the po-
tential of the Y-graft design to improve hemodynamic per-
formance is promising, and a variant of the Y-graft design
was our final recommendation for all patients.Technical Feasibility
In this work we virtually implanted a 20 3 15 3 15
Y-graft in each patient, but it should be noted that this
configuration is not currently commercially available. Our
proposed design therefore requires customized graft con-
struction for each patient using commercially availableThe Journal of Thoracic and Carsections of conduit. Space constraints may present a surgical
challenge for the PA anastomoses. Inasmuch as offsets to
both the LPA and RPAwith a 20-mm graft are routinely per-
formed already, this should indicate available space to off-
set to either side of the SVC anastomosis using a Y-graft
design. Of course, technical feasibility will be demonstrated
only through clinical implementation.
LIMITATIONS
Amain limitation in this study is the lack of postoperative
data on patients’ resistances and caval flow rates. Although
this information would not typically be available in a clini-
cal preoperative design study, the development of sophisti-
cated models that can predict changes and remodeling in
inflows and outlet boundary conditions will be crucial for
future surgical design and management of patients. The
evolution of this dynamic process is still an open question
and is beyond the scope of this study. Validation studies
of preoperative design, long-term hemodynamics, and un-
certainty analysis should be incorporated into future work.
In this study, we assumed an optimal hepatic flow distri-
bution of 50:50 and evaluated designs according to how
closely they met this criterion. The target values chosen in
this study could be adjusted on an individual basis as our un-
derstanding of the relationship between hepatic flow con-
centration and lung development is improved. Because
the theoretical optimum was not achieved for all patients
in the study, it is possible that further design optimization
may improve some underperforming Y-grafts. Future
work using patient-specific optimization would likely lead
to further design refinement in some cases, inasmuch as
this would allow for more systematic exploration of the de-
sign space. In addition, Bove and colleagues14 show lateral-
tunnel Fontan models constructed from hemi-Fontan
models result in even hepatic flow distribution and lower
power loss because of better mixing in the right atrium, so
future studies on the Y-graft should include comparisons
with the lateral-tunnel Fontan as well. Finally, inevitable
discrepancies will occur between the virtual design and its
actual surgical implementation. This introduces certain
geometric uncertainties that could result in differences be-
tween computer simulations and the actual conditions. In
addition, the use of rigid walls and the Newtonian assump-
tion for blood may affect the results presented in this study.
CONCLUSIONS
Using 5 Glenn patient–specific models, we performed
virtual Fontan operations and compared the hemodynamic
performance of the Y-graft, T-junction, and offset configu-
rations. We have demonstrated that the geometry consider-
ably influences the hepatic flow distribution, and the hepatic
flow split is not necessarily equal to the pulmonary flow
split. Theoretical analysis showed that a 50:50 hepatic
flow split is not attainable for some patients. Overall, thediovascular Surgery c Volume 143, Number 5 1095
Congenital Heart Disease Yang et al
C
H
DY-graft design results in more even hepatic flow distribution
and moderate improvements in energy loss and SVC pres-
sure. The offset design is able to achieve an even hepatic
flow distribution for patients with highly unequal pulmo-
nary flow splits, but it is sensitive to variations in pulmonary
flow split. The results of this study indicate that graft de-
signs should be optimized for individual patients before sur-
gery. In conclusion, the Y-graft is a promising new design
that warrants testing in clinical application and long-term
clinical trials. With further validation, simulations should
be used to identify the best candidates for the Y-graft proce-
dure and to rule out those patients who should continue to
receive conventional treatments.
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tise of Nathan Wilson and Charles Taylor.FIGURE 8. Based on conservation of mass, we have QRPA ¼ QIVC$xþ
QSVC$y and QLPA ¼ QIVC$ð1xÞþQSVC$ð1yÞ, where x is the fraction of
hepatic flow going to the RPA and y is the fraction of SVC flow going to
the RPA. SVC, Superior vena cava; IVC, inferior vena cava; RPA, right pul-
monary artery; LPA, left pulmonary artery; Q, flow rate.References
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APPENDIX 1
Theoretical Optimum for Hepatic Flow Distribution
We assume that hepatic flow is well mixed in the IVC
such that the hepatic and IVC flow distributions are the
same and the theoretical optimum for the hepatic flow dis-
tribution is the split closest to 50:50 that satisfies conserva-
tion of mass.
Let us derive the dependence of the hepatic flow distribu-
tion on the vena caval and pulmonary distributions (see
Figure 8 for a schematic representation of the Fontangery c May 2012
Yang et al Congenital Heart Disease
C
H
Dconfiguration). Basic conservation of mass dictates that
the ratio between the RPA flow and the LPA flow can be
defined as
QRPA
QLPA
¼ QIVC$xþQSVC$y
QIVC$ð1xÞþQSVC$ð1yÞ ¼
fs
1 fs; (1)
where Q is the flow rate, fs is the fraction of total inflow
going to the RPA, x is the fraction of hepatic flow going
to the RPA, and y is the fraction of SVC flow going to
the RPA. Then, the hepatic flow distribution can be
expressed by
x ¼ fsþQSVC
QIVC
$ðfsyÞ: (2)The Journal of Thoracic and CarEquation 2 shows that the hepatic flow distribution is a func-
tion of the inflow rates, outflow split, and percentage of
SVC flow going to the RPA.
For a given hepatic flow split x, the bounds of the RPA
flow are
QIVC$x  QRPA  QIVC$xþQSVC: (3)
Thus, a 50:50 hepatic flow split cannot exist when
QRPA<QIVC$0:5 or QRPA>QIVC$0:5þQSVC. Since QRPA is
given as boundary condition, when a 50:50 split is infeasi-
ble, the theoretical optimum for the hepatic flow distribu-
tion is defined as the value closest to 50:50 achieved
by taking y ¼ 0 or y ¼ 1, ie, QIVC$x ¼ QRPA or
QIVC$xþQSVC ¼ QRPAdiovascular Surgery c Volume 143, Number 5 1097
